美股市场上，"妖股"脑再生科技（RGC）今日盘中出现大幅下跌，跌幅高达5.79%。这一走势与该股此前的强劲表现形成鲜明对比，引发市场广泛关注。
据悉，脑再生科技近期表现极为亮眼。该公司股价从年初的0.09美元飙升至6月16日的83.6美元，累计涨幅超过175倍。仅在上一个交易日，该股就收涨逾120%。盘前交易中，脑再生科技股价一度上涨超过25%。然而，如此惊人的涨幅也引发了市场对其可持续性的质疑。
分析人士指出，脑再生科技股价的突然下跌可能是由于投资者获利回吐所致。考虑到该股近期的巨大涨幅，部分投资者可能选择在高位套现。此外，市场对该公司基本面的担忧也可能是导致股价回落的原因之一。值得注意的是，脑再生科技的核心技术——结合传统中医与前沿生物科技的"神经再生"理论，尚未得到中医界的广泛认可，也缺乏临床验证。投资者应当谨慎评估与此类高波动性股票相关的风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.